- Corporate Officers - N
- Nea 14 Gp, Ltd
Insider Trading History of Nea 14 Gp, Ltd
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Nea 14 Gp, Ltd since 2014.
This trader's CIK number is 1551532.
At the time of last reporting, Nea 14 Gp, Ltd was the 10% Owner of Imara Inc.. (stock ticker symbol IMRA).
Also see all insider trading activities at Imara Inc..
Note that in the past
NEA 14 GP, LTD also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Appian Corp (APPN) by Nea 14 Gp, Ltd
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | APPN | 0 | $0 | 3,390,136 | $66,073,749 | 0 | $0 |
Yearly summary of insider trading at Adaptimmune Therapeutics Plc (ADAP) by Nea 14 Gp, Ltd
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | ADAP | 10,839,672 | $20,008,335 | 0 | $0 | 0 | $0 |
| 2017 | ADAP | 12,870,000 | $9,009,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Imara Inc. (IMRA) by Nea 14 Gp, Ltd
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | IMRA | 0 | $0 | 291,152 | $689,029 | 0 | $0 |
Yearly summary of insider trading at Loxo Oncology, Inc. (LOXO) by Nea 14 Gp, Ltd
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2013 | LOXO | 230,769 | $2,999,997 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Tracon Pharmaceuticals, Inc. (TCON) by Nea 14 Gp, Ltd
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | TCON | 7,079,640 | $19,115,020 | 0 | $0 | 0 | $0 |
| 2016 | TCON | 869,565 | $4,999,998 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Mersana Therapeutics, Inc. (MRSN) by Nea 14 Gp, Ltd
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | MRSN | 1,000,000 | $15,000,000 | 0 | $0 | 0 | $0 |
Insider trading activities at 6 companies by Nea 14 Gp, Ltd:
1. Appian Corp (APPN)
2. Adaptimmune Therapeutics Plc (ADAP)
3. Imara Inc. (IMRA)
4. Loxo Oncology, Inc. (LOXO)
5. Tracon Pharmaceuticals, Inc. (TCON)
6. Mersana Therapeutics, Inc. (MRSN)
Table 1. Insider trading of Appian Corp (APPN) by Nea 14 Gp, Ltd
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-11-27 | APPN | Sale | 569,620 | 19.49 | 11,101,893 |
| 2017-11-20 | APPN | Sale | 2,820,516 | 19.49 | 54,971,856 |
Table 2. Insider trading of Adaptimmune Therapeutics Plc (ADAP) by Nea 14 Gp, Ltd
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-09-07 | ADAP | Buy | 3,000,000 | 1.67 | 5,001,000 |
| 2018-03-27 | ADAP | Buy | 6,000,000 | 1.92 | 11,502,000 |
| 2018-03-26 | ADAP | Buy | 571,164 | 1.90 | 1,087,496 |
| 2018-03-21 | ADAP | Buy | 104,844 | 1.81 | 189,872 |
| 2018-03-23 | ADAP | Buy | 294,090 | 1.95 | 572,299 |
| 2018-03-22 | ADAP | Buy | 869,574 | 1.90 | 1,655,668 |
| 2017-03-27 | ADAP | Buy | 12,870,000 | .70 | 9,009,000 |
Table 3. Insider trading of Imara Inc. (IMRA) by Nea 14 Gp, Ltd
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-12-21 | IMRA | Sale | 41,222 | 2.32 | 95,799 |
| 2021-12-20 | IMRA | Sale | 85,123 | 2.27 | 193,144 |
| 2021-12-16 | IMRA | Sale | 44,993 | 2.23 | 100,559 |
| 2021-12-15 | IMRA | Sale | 28,817 | 2.28 | 65,673 |
| 2021-12-14 | IMRA | Sale | 15,093 | 2.56 | 38,638 |
| 2021-12-13 | IMRA | Sale | 17,501 | 2.83 | 49,562 |
| 2021-12-09 | IMRA | Sale | 5,666 | 2.95 | 16,692 |
| 2021-12-10 | IMRA | Sale | 8,667 | 2.83 | 24,544 |
| 2021-12-23 | IMRA | Sale | 23,961 | 2.41 | 57,746 |
| 2021-12-22 | IMRA | Sale | 20,109 | 2.32 | 46,672 |
Table 4. Insider trading of Loxo Oncology, Inc. (LOXO) by Nea 14 Gp, Ltd
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2013-08-06 | LOXO | Buy | 230,769 | 13.00 | 2,999,997 |
Table 5. Insider trading of Tracon Pharmaceuticals, Inc. (TCON) by Nea 14 Gp, Ltd
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-03-27 | TCON | Buy | 707,964 | 2.70 | 1,911,502 |
| 2018-03-27 | TCON | Buy | 707,964 | 2.70 | 1,911,502 |
| 2018-03-27 | TCON | Buy | 707,964 | 2.70 | 1,911,502 |
| 2018-03-27 | TCON | Buy | 707,964 | 2.70 | 1,911,502 |
| 2018-03-27 | TCON | Buy | 707,964 | 2.70 | 1,911,502 |
| 2018-03-27 | TCON | Buy | 707,964 | 2.70 | 1,911,502 |
| 2018-03-27 | TCON | Buy | 707,964 | 2.70 | 1,911,502 |
| 2018-03-27 | TCON | Buy | 707,964 | 2.70 | 1,911,502 |
| 2018-03-27 | TCON | Buy | 707,964 | 2.70 | 1,911,502 |
| 2018-03-27 | TCON | Buy | 707,964 | 2.70 | 1,911,502 |
| 2016-11-29 | TCON | Buy | 869,565 | 5.75 | 4,999,998 |
Table 6. Insider trading of Mersana Therapeutics, Inc. (MRSN) by Nea 14 Gp, Ltd
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-07-03 | MRSN | Buy | 1,000,000 | 15.00 | 15,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Nea 14 Gp, Ltd
(10% Owner of Imara Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.